CD44 and breast carcinoma: Moreover, miR-203 and miR-150 can regulate the expression of DNMT3A and DNMT3B in breast cancer cells, resulting in regulation of CD44, ALDH1A3, OCT3/4, SOX2 expression, which are critical for breast cancer stem cell development (El-Osaily et al., 2021).